Bayer Aktiengesellschaft (BAYN.XETRA)

Exchange: XETRA Exchange
Currency: EUR

Price: 58.01 (Close)



52 Week range 200d Moving Avg. Beta
43.91 – 58.01 49.52 1.21
Dividend Dividend Yield Ex-Dividend date
2.00 3.45% 2022-05-02
P/E Ratio Latest EPS DGR 3 years
56.98 1.02 -10.61%
High Volatility
Dividend Growth


Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, cosmetics, and self-care solutions in the dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, cold and cough, foot care, and sun protection categories. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The Animal Health segment develops and markets products and solutions for the prevention and treatment of disease in companion and farm animals to veterinarians. Bayer Aktiengesellschaft has a collaboration agreement with MD Anderson Cancer Center at the University of Texas to develop cancer treatments; and research collaboration agreements with Haplogen GmbH and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. The company distributes its products through wholesalers, pharmacies, supermarket and drugstore chains, online and other retailers, and hospitals, as well as directly to farmers. It has strategic research alliance with Kyoto University to jointly identify new drug targets for the treatment of pulmonary diseases, such as idiopathic pulmonary fibrosis; and with Sensyne Health plc. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.


Sector: Industry:
Healthcare Drug Manufacturers – Major

Environment, Social and Governance (ESG) Ratings

Total ESG Score

38 – 79 percentile


10 – 8 percentile


29 – 8 percentile


14 – 8 percentile

Controversy level



see MSCI ESG rating explained

Dividend Safety Metrics

Latest EPS 1.02
Annual Payout 2.00
Payout Ratio 196.08%
Dividend growth 0 Years
Dividend Score 63
Dividend Coverage Ratio 0.51
Altman-Z score 0.00


Bayer Aktiengesellschaft (BAYN.XETRA) Valuation

Bayer Aktiengesellschaft current dividend yield of 3.45% is -19% below its 5-year average. The 5-year average dividend yield is 4.24% (see red-line in chart). This indicates the stock looks overvalued today.

Bayer Aktiengesellschaft (BAYN.XETRA) Performance

The chart below displays the total price return(%) of Bayer Aktiengesellschaft for different periods:


Bayer Aktiengesellschaft (BAYN.XETRA) Total Return

The chart below displays the (CAGR) total return (%) including all dividends paid of Bayer Aktiengesellschaft for different periods:


Dividend Scorecard

Dividend Yield (TTM) Annual Payout Payout Ratio Dividend growth
3.45 2.00 196.08% 0 Years


Dividend Growth Summary

3 Year Growth Rate (CAGR) -10.61%
5 Year Growth Rate (CAGR) -4.36%
10 Year Growth Rate (CAGR) 2.92%

Dividend Growth Rates History

Year Payout Amount Annual Payout Growth (YoY)
2021 2.000 -28.6%
2020 2.800 0.0%
2019 2.800 0.0%
2018 2.800 3.7%
2017 2.700 8.0%
2016 2.500 11.1%
2015 2.250 7.1%
2014 2.100 10.5%
2013 1.900 15.2%
2012 1.650 10.0%
2011 1.500 7.1%
2010 1.400 0.0%
2009 1.400 3.7%
2008 1.350 35.0%

Bayer Aktiengesellschaft (BAYN.XETRA) Dividend Payment History